The p53 tumor suppressor protein is a key regulator of cell cycle and death that is involved in many cell signaling pathways and is tightly regulated in mammalian cells. Posttranslational modifications of p53 have been previously investigated mainly using antibodies.
INTRODUCTION
p53 plays a key role in cellular homeostasis and is at the heart of a complex network of protective mechanisms safeguarding cellular integrity. Due to its central function in processes such as cell cycle regulation, apoptosis, DNA repair, cellular senescence and apoptosis, the p53 pathway is crucial for effective tumor suppression, and mutations in p53 that compromise its function occur in more than 50% of cancers (1, 2) . Interestingly, p53 appears to be highly post-translationally modified and although ubiquitination, neddylation, sumoylation and methylation have been described, phosphorylation and acetylation are the most commonly reported modifications of p53 (3) . Both phosphorylation and acetylation affect p53 stability and activity and are induced following various types of stress (4) . For example, phosphorylation at Ser-15, Ser-20, Thr-18 and Ser-37 disrupts the interaction between p53 and its major negative regulator, MDM2 (3, 5) , leading to an increase of p53 protein expression and activity. The acetylation sites are located mostly in the C-terminal end of p53 where the tetramerization and regulatory domains localize. Sites of acetylation have been reported at lysine residues -120, -164, -305, -320, -370, -372, -373, -381, -382 and 386 (6) (7) (8) (9) (10) (11) (12) (13) (14) and importantly, acetylation has recently been shown to be indispensable for p53 activation (14) . In this context of high regulation of p53 through post-translational modifications, we aimed at identifying potential new p53 modifications by using mass spectrometry. p53 was obtained from the kidney fibroblast-like Cos-1 cells which are known to produce a high amount of p53. In fact, in these cells, p53 is bound to SV40 large T antigen (15, 16, 17) . This association sequesters the gene transactivation function of p53, rendering it inactive as a transcription factor. The sequestration leads to an accumulation of p53 as part of a complex with SV40 large T antigen (17). Utilizing collision-induced dissociation (CID) analysis and high accuracy mass measurements, a number of different modifications, both known and novel, were deciphered. They encompass phosphorylation of H 2 O. The TEA eluate was immediately neutralized using 0.25 volumes of 1 M Tris (pH 6.8).
Resulting lysates were then loaded and fractionated on a SDS-PAGE gel (10%, Novex, Invitrogen).
Identification of p53 post-translational modifications by mass spectrometry.
After being separated by SDS-PAGE and Coomassie blue stained (Simply Blue, Invitrogen), the p53 protein band was excised and processed for digestion with trypsin (Promega) or Asp-N (Roche) as described in (18), with minor modifications. In brief, 100 ng of trypsin or AspN, was used for each gel band, and digestions were carried out at 37 °C. Peptides were extracted from gel pieces with 100 µl of 50% acetonitrile, 2% formic acid twice, vacuum centrifuged to dryness and resuspended in 10 μl of 0.1% formic acid in water prior to analysis of 1ul. The peptides were fractionated by reversed phase high pressure liquid chromatography using an Eksigent 1D NanoLC system (Dublin, CA). The column was a 100 um ID x 150 mm self-packed column with Ultro120 (Peeke Scientific, Redwood City, CA) C-18 resin. The flow rate was 350 nl/min, solvents were water/0.1% formic acid (A) and acetonitrile/0.1% formic acid (B), and the gradient was 5-30% B over 40 minutes. The HPLC system was coupled to a QSTAR Pulsar (of Qq-oaTOF geometry; MDS Sciex, of R, dimethylation of R, methylation of H, methylation of E, ubiquitination of K. The mass tolerance for precursor ions was set at 100 ppm and the mass tolerance for fragment ions at 0.8 Da and for LTQ-FT 20 ppm and 0.6 Da respectively. The threshold for peptide score and maximum E-value for accepting individual MS/MS spectra were 15 and 0.01 respectively.
All modification site assignments were determined by manual spectrum interpretation. This emphasizes the advantages of using different proteolytic enzymes in protein characterization. The tryptic digest yielded 87% of the p53 sequence, while the Asp-N digest yielded 50% sequence coverage. The use of two different mass spectrometers, in this case, did not alter the sequence coverage observed in each digest.
RESULTS

Sequencing of p53 protein in
Identification of known p53 post-translational modifications.
The data acquired were searched allowing for a wide variety of modifications and all modified spectra reported here were manually verified. As shown in Table 1 , several peptides were identified acetylated and phosphorylated, resulting in a total (known plus unknown) of 13 different residues modified along the p53 protein. Phosphorylation was detected on 2 residues near the N-terminus of the protein. One was located on serine-15 and the CID spectrum to support this assignment is shown in Figure 2a . The phosphorylation site was identified due to the detection of unmodified y 7 and y 8 ions, whilst y 11 and y 12 were both shifted by the mass of a phosphate group. Of the three residues between these fragments, LSQ, serine-15 is the only residue that can be phosphorylated.
The other phosphorylation identified in the N-terminal region was on serine-33. In the spectrum in Figure 2b Another phosphorylation was also deciphered on the penultimate residue of the protein, on serine-392. Figure 2f shows the corresponding CID spectrum. All y ions observed are shifted by the mass of the phosphate group. Two other modifications were also deciphered: acetylation on lysine-305 and phosphorylation on serine-315. Although these two modifications occur in the same tryptic peptide, they were not observed together. Their corresponding CID spectra are presented in Figures 3g and 3h , respectively. The last modification was found at the C-terminal end of the protein: acetylation of Lys-386 was detected. Interestingly, this modification was observed only in combination with two other modifications: acetylation on lysine-382 and phosphorylation on serine-392. The corresponding CID spectrum (m/z 783.31(2+)) is shown in Figure 2i . The y ion-series from y 2 onwards includes the phosphorylation on serine-392. The next mass shift is between the y 7 and y 8 ions, identifying lysine-386 acetylation. All b ions display the mass shift corresponding to lysine-382 acetylation.
Identification of novel p53 post-translational modifications.
The experiments also allowed new modifications to be uncovered. Acetylation on lysine-319 was identified. As shown in Figure 3a , an unmodified y 1 followed by a modified y 2 ion allowed the identification of lysine-319 as the acetylated amino acid. Lysine-357 was also detected acetylated. The CID spectrum in Figure 3b shows an unmodified y 6 but a modified y 7 ion, allowing the residue of modification to be pinpointed. These two modified residues border the tetramerization domain of p53 ( Figure 4 ).
DISCUSSION
We have identified phosphorylation and acetylation sites on endogenous p53 from Cos-1 cells. The phosphorylation sites detected were localized at the N-and C-terminal ends of the protein on serines-15, -33, -315 and -392. Our results confirmed some phosphorylation sites previously described by Tack and Wright using Edman sequencing and radiolabeling (20).
They identified phosphorylation on Ser-9, Ser-15, Ser-20, either Ser-33 or Ser-37, at least one of Ser-90 or Ser-99, Ser-315 and Ser-392. The new results presented here were able to pinpoint phosphorylation on Ser-33, resolving ambiguity for one of the sites in their study. Ser-37 has been shown to lead to a conformational change in p53 that prevents its interaction with MDM2, thus inhibiting p53 ubiquitination and degradation. In our case, only Ser-15 was detected phosphorylated. We can hypothesize that the binding of large T antigen to p53 by itself could stabilize p53. Hence, it has been proposed that large T antigen enhances the stability of p53 partly by complexing with MDM2 (30, 31). In our experiment, we identified large T antigen in the p53 pull down assay but not MDM2. p53 N-terminal phosphorylation can also promote the binding of the acetyltransferases CBP/p300 to p53 (3). Kishi and colleagues (32) suggested that phosphorylation of Ser-33 may stimulate acetylation of p53. Upon stress, p53 is known to be specifically acetylated at lysine residues (in positions -164, 370, 372, 373, 381 and 382) by CBP/p300 (6,13), at Lys-320 by p300/CBP associated factor (PCAF) (7), at Lys-305 by p300 (10) and at Lys-120 by the p19ARF/oncogene pathway (33, 34). It was also demonstrated that Tip60, Ada3, and Pin1 participate in the control of p53 acetylation (8, 35, 36) . The effects of acetylation on p53 function are not totally clear, but they have been implicated in modulating p53 transcriptional activity and stability (37) . Like the acetylation of lysine residues in histones, acetylation of p53 has been linked to gene transcription regulation. Knights and coworkers showed that distinct p53 acetylation "cassettes" differentially influence gene-expression patterns and cell survival versus death (38) . Acetylation sites are also important to keep p53 from ubiquitination and subsequent degradation by MDM2 as p53 is ubiquitinated and acetylated on similar sites at the carboxyl terminus (39, 40) , suggesting that these modifications may compete for the same residues. Importantly, recent work by Tang and coworkers described p53 acetylation as an indispensable event that destabilizes the p53-Mdm2 interaction enabling p53 activation (14) . In our study, lysines -319 and -357, observed acetylated, border the tetramerization domain of p53 (Figure 4) . The recent crystal structure of large T antigen complexed with p53 revealed a hexameric complex of large T antigen binding six p53 monomers (29) and one could speculate that the new acetylation sites that we report here might impact p53 conformation and eventually participate in the formation and stabilization of the complex with large T antigen.
In conclusion, our study confirmed that p53 is a highly acetylated protein and unveiled new acetylation sites. Given the increasingly reported importance of acetylation for the regulation of p53, and although further functional exploration will be needed, the new acetylation sites identified here open new perspectives for the refinement of p53 mechanism of regulation. Joubel et al. Joubel et al.
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